‘Pharma Bro’, who drove up anti-HIV drug costs by defrauding investors, gets imprison

The “Pharma Bro” was convicted last year to defraud financial specialists by demonstrating counterfeit record explanations of two failing hedge funds that he ran.

The main drug prices that were used to treat HIV was driven up 50 times by the Martin Shkreli, a previous drug firm executive has been condemned seven-year imprisonment by a New York government court for cheating investors.

The “Pharma Bro” was indicted a year ago to defraud investors by demonstrating counterfeit record explanations of two failing hedge funds that he ran.

As per the PBS reports, the 34-year-old pharmaceutical official, who had gained notoriety for driving up the cost of HIV medicine in 2015 and trolling commentators on the web, cried in the court and apologized to investors and said “I am terribly sorry I lost your trust,” he reportedly said in the court. “You deserve far better.

In spite of the fact that his lawyers requested for tolerance in condemning, the U.S. District Judge Kiyo Matsumoto termed his crimes seriously and handed him the sentence.

Related Posts

Licences of 20 medical stores suspended after inspections

Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

NEW DELHI: Global investment firm Bain Capital has divested nearly a 1 per cent stake in Emcure Pharmaceuticals for over Rs 289 crore through open market transactions, according to the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket